Literature DB >> 2319649

Cell-type-specific control elements of the lymphotropic papovavirus enhancer.

J R Erselius1, B Jostes, A K Hatzopoulos, L Mosthaf, P Gruss.   

Abstract

Lymphotropic papovavirus (LPV) exhibits a highly restricted host range, in which only cells of primate B-lymphocyte origin are permissive for infection. Its enhancer element contributes to this tropism, since transcriptional potentiation is confined to cells of the hematopoietic lineage. Nuclear extracts from B and T cells, but not from HeLa cells, contain protein factors that interact specifically with the LPV 63-base-pair enhancer repeat, as demonstrated by DNase I footprinting and gel retardation experiments. Within the repeat three sequence motifs were identified: the core motif, the Pu box, and a novel element named T motif. Functional analysis demonstrated that these motifs as well as some sequences upstream of the repeat contribute to the optimal activity of the enhancer. There are clear differences between the patterns of binding of the B and T lymphocyte nuclear proteins to the enhancer which are also reflected in the transcriptional activity of the enhancer in both cell types. Furthermore, the activity of the LPV enhancer and its interaction with nuclear proteins seem to be regulated during B-cell differentiation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2319649      PMCID: PMC249302     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  The SV40 enhancer can be dissected into multiple segments, each with a different cell type specificity.

Authors:  S Schirm; J Jiricny; W Schaffner
Journal:  Genes Dev       Date:  1987-03       Impact factor: 11.361

2.  Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism.

Authors:  R Sen; D Baltimore
Journal:  Cell       Date:  1986-12-26       Impact factor: 41.582

3.  Distinct factors bind to apparently homologous sequences in the immunoglobulin heavy-chain enhancer.

Authors:  J Weinberger; D Baltimore; P A Sharp
Journal:  Nature       Date:  1986 Aug 28-Sep 3       Impact factor: 49.962

4.  Specific protein binding to the simian virus 40 enhancer in vitro.

Authors:  A G Wildeman; M Zenke; C Schatz; M Wintzerith; T Grundström; H Matthes; K Takahashi; P Chambon
Journal:  Mol Cell Biol       Date:  1986-06       Impact factor: 4.272

5.  Electroporation for the efficient transfection of mammalian cells with DNA.

Authors:  G Chu; H Hayakawa; P Berg
Journal:  Nucleic Acids Res       Date:  1987-02-11       Impact factor: 16.971

Review 6.  Some properties and applications of monoclonal antibodies.

Authors:  P A Edwards
Journal:  Biochem J       Date:  1981-10-15       Impact factor: 3.857

7.  Nuclear factors binding specific sequences within the immunoglobulin enhancer interact differentially with other enhancer elements.

Authors:  U Schlokat; D Bohmann; H Schöler; P Gruss
Journal:  EMBO J       Date:  1986-12-01       Impact factor: 11.598

8.  Discrete elements within the SV40 enhancer region display different cell-specific enhancer activities.

Authors:  B Ondek; A Shepard; W Herr
Journal:  EMBO J       Date:  1987-04       Impact factor: 11.598

9.  Cell type-specificity elements of the immunoglobulin heavy chain gene enhancer.

Authors:  T Gerster; P Matthias; M Thali; J Jiricny; W Schaffner
Journal:  EMBO J       Date:  1987-05       Impact factor: 11.598

10.  A family of octamer-specific proteins present during mouse embryogenesis: evidence for germline-specific expression of an Oct factor.

Authors:  H R Schöler; A K Hatzopoulos; R Balling; N Suzuki; P Gruss
Journal:  EMBO J       Date:  1989-09       Impact factor: 11.598

View more
  8 in total

1.  JC virus promoter/enhancers contain TATA box-associated Spi-B-binding sites that support early viral gene expression in primary astrocytes.

Authors:  Leslie J Marshall; Lisa D Moore; Matthew M Mirsky; Eugene O Major
Journal:  J Gen Virol       Date:  2011-11-09       Impact factor: 3.891

Review 2.  Vectors for cancer gene therapy.

Authors:  J Zhang; S J Russell
Journal:  Cancer Metastasis Rev       Date:  1996-09       Impact factor: 9.264

Review 3.  Molecular regulation of JC virus tropism: insights into potential therapeutic targets for progressive multifocal leukoencephalopathy.

Authors:  Leslie J Marshall; Eugene O Major
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-17       Impact factor: 4.147

4.  Mouse beta-globin DNA-binding protein B1 is identical to a proto-oncogene, the transcription factor Spi-1/PU.1, and is restricted in expression to hematopoietic cells and the testis.

Authors:  D L Galson; J O Hensold; T R Bishop; M Schalling; A D D'Andrea; C Jones; P E Auron; D E Housman
Journal:  Mol Cell Biol       Date:  1993-05       Impact factor: 4.272

5.  A transcriptional regulatory element is associated with a nuclease-hypersensitive site in the pol gene of human immunodeficiency virus type 1.

Authors:  C Van Lint; J Ghysdael; P Paras; A Burny; E Verdin
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

6.  Induction versus progression of brain tumor development: differential functions for the pRB- and p53-targeting domains of simian virus 40 T antigen.

Authors:  M T Sáenz Robles; H Symonds; J Chen; T Van Dyke
Journal:  Mol Cell Biol       Date:  1994-04       Impact factor: 4.272

7.  Transcription factor Spi-B binds unique sequences present in the tandem repeat promoter/enhancer of JC virus and supports viral activity.

Authors:  Leslie J Marshall; Lisa Dunham; Eugene O Major
Journal:  J Gen Virol       Date:  2010-09-08       Impact factor: 3.891

8.  Transcription factor binding sites in the pol gene intragenic regulatory region of HIV-1 are important for virus infectivity.

Authors:  Véronique Goffin; Dominique Demonté; Caroline Vanhulle; Stéphane de Walque; Yvan de Launoit; Arsène Burny; Yves Collette; Carine Van Lint
Journal:  Nucleic Acids Res       Date:  2005-08-01       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.